LETTER FROM THE EDITOR-IN-CHIEF.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Works matching IS 21660166 AND DT 2014 AND VI 3 AND IP 1
Results: 26
1
2
New Technology Diffusion Essential to Personalized Medicine.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 66
- Publication type:
- Article
3
Hematologists Often Ignore Treatment and Monitoring Recommendations.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 63
- Publication type:
- Article
4
Novel CAR-T Therapy Topped the News at ASH.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 62
- Publication type:
- Article
5
FIRST Trial Shows Value of Continued Use of Lenalidomide in Newly Diagnosed Myeloma Patients.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 61
- Publication type:
- Article
6
Ph+ CML: Deep Molecular Response Achieved and Sustained More Often With Nilotinib.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 59
- Publication type:
- Article
7
More Transplants Made Possible Through Haploidentical Donors.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 58
- Publication type:
- Article
8
Anti-CD20 Agent Improves Outcomes in Elderly/Unit Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 57
- Publication type:
- Article
9
ALL: Genetics Providing New Insights Into Signaling Pathways and Treatment Targets.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 56
- Publication type:
- Article
10
Novel Anti-CD20 Antibody Superior to Rituximab on Progression-Free Survival in Unit CLL Patients.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 55
- Publication type:
- Article
11
Breast Cancer Agents in the Pipeline.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 46
- Publication type:
- Article
12
Adjuvant Bisphosphonates: Winner in Postmenopausal Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 46
- Publication type:
- Article
13
Hematologists Question Panel About Guidelines and Performance Measures.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 52
- Publication type:
- Article
14
Case Study: Use of Biomarkers in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 50
- Publication type:
- Article
15
I-SPY 2: First Results Based on Biomarkers/Genetic Signatures in Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 47
- Publication type:
- Article
16
Idelalisib Improves Outcomes in Heavily Pretreated CLL Patients.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 54
- Publication type:
- Article
17
Lenalidomide as Maintenance in Transplant Myeloma Population Still Debated.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 53
- Publication type:
- Article
18
Need for Innovative Strategies for Quality Care Will Continue to Grow.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 44
- Publication type:
- Article
19
Clinical Approaches to Targeted Technologies: Highlights from the Second Annual Conference of the Global Biomarkers Consortium.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 32
- By:
- Publication type:
- Article
20
Pharmacologic Perspectives on Novel Therapies in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 29
- By:
- Publication type:
- Article
21
Nursing Strategies for Improved Outcomes in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 27
- By:
- Publication type:
- Article
22
The Significance of Achieving Complete Response in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 25
- By:
- Publication type:
- Article
23
LETTER FROM THE EDITOR-IN-CHIEF.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 24
- By:
- Publication type:
- Article
24
Partners HealthCare Center for Personalized Genetic Medicine: Utilizing Genetics and Genomics to Improve Care of Patients.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 18
- Publication type:
- Article
25
PROGRESS REPORT: Implementation of ASCO's Blueprint for Transforming Clinical and Translational Cancer Research.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 14
- Publication type:
- Article
26
The Importance of the Multidisciplinary Team in Personalizing Care.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 12
- By:
- Publication type:
- Article